Diagnostics

The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment

The Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) will create the largest open data platform for ALS research…

6 months ago

Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

ANN ARBOR, MI / ACCESSWIRE / May 21, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

6 months ago

APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau) for the Diagnosis of Progressive Supranuclear Palsy

Fast Track Designation follows announcement in January 2024 that the U.S. Food and Drug Administration (FDA) granted a “Study May…

6 months ago

Spectral AI Announces Purchases of Over 100,000 Shares by Insiders

DALLAS, May 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

6 months ago

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patientsManassas, Virginia--(Newsfile Corp. -…

6 months ago

Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform

OTA capability enhances introduction of new assays from rapidly expanding menuANN ARBOR, MI / ACCESSWIRE / May 15, 2024 /…

6 months ago

West Tennessee Healthcare Expands Use of AI to Elevate and Personalize Emergency Department Patient Visits

JACKSON, Tenn.--(BUSINESS WIRE)--West Tennessee Healthcare has announced the full integration of Vital’s ERAdvisor platform across its seven emergency departments (EDs),…

6 months ago

CLIAwaived, Inc. Named First Authorized Approved Distributor for Wondfo USA’s new WELLlife(TM) COVID-19/Influenza A&B POC and Home (OTC) Tests

CLIAwaived, Inc. has been named the first authorized approved distributor for Wondfo USA's innovative WELLlife™ COVID-19/Influenza A&B Point-of-Care (POC) and…

6 months ago

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

Collaboration seeks to advance precision care by providing an alternative, non-invasive approach to the assessment of coronary physiology. Both companies…

6 months ago

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

Collaboration seeks to advance precision care by providing an alternative, non-invasive approach to the assessment of coronary physiology. Both companies…

6 months ago